Findings

What do systematic reviews say?

2 questions · 2 findings · 2 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 1 · 50%Low 1 · 50%Moderate 0 · 0%High 0 · 0%

Terlipressin vs placebo or no intervention

Hepatorenal syndrome · people with hepatorenal syndrome

Terlipressin may leads to lower hepatorenal syndrome compared with placebo or no intervention (low certainty).

1 finding from 1 review

Terlipressin versus placebo or no intervention for people with cirrhosis and hepatorenal syndrome 2017 · Cochrane Headline outcomes only
RR 0.63 [0.48, 0.82]
7 studies · 510 participants
Low

Terlipressin vs other vasoactive drugs

Hepatorenal syndrome (Number of participants who did not achieve reversal of hepatorenal syndrome) · people with cirrhosis and hepatorenal syndrome

It is very uncertain whether terlipressin changes hepatorenal syndrome (Number of participants who did not achieve… compared with other vasoactive drugs (very low certainty).

1 finding from 1 review

Terlipressin versus other vasoactive drugs for hepatorenal syndrome 2017 · Cochrane Headline outcomes only
RR 0.79 [0.63, 0.99]
394 participants
Very low